アンドロゲンおよびアナボリックステロイドの世界市場 - 2022年～2029年

当レポートでは、世界のアンドロゲンおよびアナボリックステロイド市場について調査し、市場の概要とともに、 合成誘導体別、投与方法別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 世界のアンドロゲンおよびアナボリックステロイド市場の調査手法と範囲

第2章 世界のアンドロゲンおよびアナボリックステロイド市場-市場の定義と概要

第3章 世界のアンドロゲンおよびアナボリックステロイド市場-エグゼクティブサマリー

• 合成誘導体別市場内訳
• 投与方法別市場内訳
• 用途別市場内訳
• エンドユーザー別市場内訳
• 地域別市場内訳

第4章 世界のアンドロゲンおよびアナボリックステロイドの市場-市場力学

• 市場に影響を与える要因
  • 促進要因
  • 抑制要因
  • 市場機会
  • 影響分析

第5章 世界のアンドロゲンおよびアナボリックステロイド市場-業界分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析

第6章 世界のアンドロゲンおよびアナボリックステロイド市場-COVID-19分析

第7章 世界のアンドロゲンおよびアナボリックステロイド市場- 合成誘導体別

• イントロダクション
  • 市場規模分析、および前年比成長分析（％）、 合成誘導体別
  • 市場魅力指数、 合成誘導体別
• 17アルファアルキル誘導体
  • イントロダクション
  • 市場規模分析、100万米ドル（2020年～2029年）、および対前年比成長分析（％）（2021年～2029年）
• 17ベータエステル誘導体

第8章 世界のアンドロゲンおよびアナボリックステロイドの市場-投与方法別

• イントロダクション
  • 市場規模分析、および前年比成長分析（％）、投与方法別
  • 市場魅力指数、投与方法別
• 経口
  • イントロダクション
  • 市場規模分析、100万米ドル（2020年～2029年）、および対前年比成長分析（％）（2021年～2029年）
• 注入
• 局所
• スキンパッチ
• 吸入器

第9章 世界のアンドロゲンおよびアナボリックステロイド市場-エンドユーザー別

• イントロダクション
  • 市場規模分析、および前年比成長分析（％）、エンドユーザー別
  • 市場魅力指数、エンドユーザー別
• 院内薬局
  • イントロダクション
  • 市場規模分析、100万米ドル（2020年～2029年）、および対前年比成長分析（％）（2021年～2029年）
• 小売薬局
• オンライン薬局
• その他

第10章 世界のアンドロゲンおよびアナボリックステロイド市場-地域別

• イントロダクション
  • 市場規模分析、100万米ドル（2020年～2029年）、および対前年比成長分析（％）（2021年～2029年）、地域別
  • 市場魅力指数、地域別
• 北米
• 欧州
• 南米
• アジア太平洋
• 中東・アフリカ

第11章 世界のアンドロゲンおよびアナボリックステロイド市場-競合情勢

• 主な発展と戦略
• 企業シェア分析
• 製品のベンチマーク
• 注目すべき主要企業

第12章 世界のアンドロゲンおよびアナボリックステロイド市場-企業プロファイル

• Endo Pharmaceuticals Solutions Inc
• Valeant
• Taro Pharmaceuticals Inc
• Antares Pharmaceuticals Inc
• Actavis Pharmaceuticals Inc
• Pfizer
• Unimed Pharmaceuticals
• GlaxoSmithKline plc

第13章 世界のアンドロゲンおよびアナボリックステロイド市場-DataM

Market Overview

The global androgens and anabolic steroids market size was valued US$ XX million in 2020 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

Di-hydro-testosterone, testosterone, and other anabolic steroids are examples of male sex hormones and anabolic steroids. Androgen and anabolic steroids promote the growth of male sex organs and male sexual characteristics such as beard growth and voice deepening. Anabolic steroids stimulate the growth of various tissues, including muscle and bone. Anabolic effects cause an increase in red blood cell formation. Androgens and anabolic steroids are used to treat breast cancer in women, impotence, hypogonadism in men, and replacement therapy for adolescent boys experiencing delayed puberty. Androgens and anabolic steroids are also used to treat hormonal imbalances, weight loss, osteoporosis, and anemia, among other things.

Market Dynamics

The commercial center for androgens and anabolic steroids is growing as the geriatric population grows, as more men are susceptible to hypogonadism. In addition, as men's weight problems worsen, the market for androgens and anabolic steroids grows. The expanding unfavorable health state, particularly in developing countries, is expected to fuel market expansion during the forecast period.

Increasing trends among youngsters for bodybuilding is creating robust development will drive the market growth

One of the major factors driving the androgens and anabolic steroids market is the growing popularity of bodybuilding among young people. Steroids are the performance-enhancing substance that is utilized all over the world. The demand for steroids has expanded dramatically due to the increase in sporting events, which has a favorable impact on the global market for steroids. Steroids can enhance pubic and facial hair growth. It not only improves attention and ambition, but it also deepens the voice. As a result, steroids are beneficial to excessively feminine hormones.

Furthermore,the expansion of the overall androgens and anabolic steroids market is attributable to increased government endeavors for better human services. Throughout the projected period, the global androgens and anabolic steroids market is expected to grow due to an increase in hypogonadism among males. During the projection period, an increase in impotence among men due to weight problems and fatigue is expected to boost demand for androgens and anabolic steroids. Hypogonadism affects 4 to 5 million men in the United States, and while it can affect men of any age, low testosterone levels are more frequent in older men. More than 60% of men over 65 have free testosterone levels that are lower than those of men in their 30s and 35s. (Source:Boston University School of Medicine). Erectile Dysfunction affects roughly 10% of males every decade of their lives. Erectile Dysfunction affects 50 percent of men in their 50s, for example. (2019, University of Wisconsin Health).

Furthermore, the proportion of the world's population aged 60 and up will nearly double from 12 percent to 22 percent between 2015 and 2050.By 2023, the number of persons aged 60 and more will outweigh youngsters under five.By 2050, 80% of the world's elderly will live in low- and middle-income countries.The population is aging at a considerably higher rate than in the past.(Source:World Health Organization).This contributes to the growth of the global androgens and anabolic steroids market.

Side effects of steroids is likely to hamper the market growth

Steroid use comes with many negative side effects, including fast mood changes. Heart problems, fertility troubles, testicular shrinkage, and excessive hair growth in women are stifling the worldwide steroid market's expansion. Any drug's use is restricted because the government establishes guidelines to monitor how and where the medications are utilized. This is expected to influence the market for androgens and anabolic steroids negatively. Furthermore, these medicines have negative effects that may cause them to be used less frequently. To overcome these limitations, the market must continue to develop and upgrade.

COVID-19 Impact Analysis

During the COVID-19 pandemic, the androgens and anabolic steroids market had shrinked significantly. The pandemic has made it tougher to bring new medications to market in the hopes of earning market share or reaching sales projections. Aside from new diagnoses and regimen switching, marketing channels aren't as strong as before the epidemic. The few open channels continue to be dominated by COVID-19 programming. COVID-19 has slowed down clinical trials across the board, notably those in the early stages of development. As traditional study sites closed, researchers were often unable to collect data remotely, and many patients became less willing to participate. Some therapeutic fields were particularly heavily damaged. While some development time can be made up, there are concerns about resource allocation and digital technology expenditures to keep trials running now and in the future.

Segment Analysis

The injection segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The injections segment is being propelled by high unmet demands, rising prevalence of bone and joint illnesses, government awareness campaigns for joint disorders, an increase in obese population due to bad lifestyles, and advantageous health care insurance coverage. Globally, 50 million people have been diagnosed with some form of arthritis, according to the Statistic Brain Research Institute. Other factors driving the worldwide steroid injections market include rising health awareness, advancements in steroid injection treatment, and increased demand for steroid injections.

Arthritis affects nearly 180 million individuals in India, according to Arthritis-India. Many well-known diseases, such as diabetes, AIDS, and cancer, have a higher prevalence than this. By 2025, India will be the world's osteoarthritis capital, with over 60 million people expected to be affected.Due fast and effective results the demand for steroid injections are increasing rapidly resulting in the growth of this segment.

Geographical Analysis

North America region holds the largest market share of global androgens and anabolic steroids market

The anabolic steroid market in North America held the largest market share because of the increased occurrence of breast cancer in women. According to numerous studies, breast cancer is one of the leading causes of death in the United States. Because of the rapid occurrence of hypogonadism in men and delayed puberty in teenage boys, Europe has the second biggest proportion of the anabolic steroid industry. Breast cancer is one of the most common cancers among women, regardless of race or ethnicity, according to the Centers for Disease Control and Prevention (CDC) statistics from 2018. It is also the third-leading cause of cancer death in American Indian/Alaska Native women.

Breast cancer was the most common type of cancer in 2020, according to a Globocan report, with a prevalence rate of 11.7 percent. According to the same report, Asia had the highest five-year prevalence rate for both sexes at 3,218,496 (41.3 percent), followed by Europe at 2,138,117 (27.4 percent) and North America with 1.189,111 people (15.3 percent ). The Asia Pacific anabolic steroids market is predicted to grow rapidly over the forecast period, owing to increased government measures to combat breast cancer.

Improved prevalence of impotence, hypogonadism in men, and late puberty in adolescent boys are expected to enhance the anabolic steroids industry in the Middle East and Africa. Due to faster government tasks in the fitness care sector, the market in Latin America is expected to grow strongly at some point during the forecast period.

Competitive Landscape

The androgens and anabolic steroids market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Valeant , Endo Pharmaceuticals Solutions Inc, Taro Pharmaceuticals Inc, Antares Pharmaceuticals Inc, Actavis Pharmaceuticals Inc, Pfizer, Unimed Pharmaceuticals, GlaxoSmithKline plc. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the androgens and anabolic steroids market globally. For instance, in November 2018, Antares Pharma announced the commercialization of XYOSTEDTM (Testosterone Enanthate) Injection - a new treatment for adult men with testosterone deficiency.

Endo Pharmaceuticals Solutions Inc

Overview: Endo International PLC is a specialty pharmaceutical firm that specializes in pain treatment, urology, orthopedics, endocrinology, bariatrics, and other fields. Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals are the company's four segments.

Product Portfolio:

Aveed: Aveed is a testosterone-containing prescription medication. Aveed is a prescription medication for adult males who have little or no testosterone due to certain medical disorders. Aveed is exclusively prescribed to adult males who require testosterone replacement therapy and whose benefit outweighs the risk of POME and anaphylaxis.

Why Purchase the Report?

Visualize the composition of the global androgens and anabolic steroids market segmentation by synthetic derivates, mode of administration, applications, end user and region highlighting the key commercial assets and players.

Identify commercial opportunities in global androgens and anabolic steroids market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global androgens and anabolic steroids market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global androgens and anabolic steroids market report would provide an access to an approximately 40+ market data table, 45+ figures and 180 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. Global Androgens and Anabolic Steroids Market Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Global Androgens and Anabolic Steroids Market- Market Definition and Overview

3. Global Androgens and Anabolic Steroids Market- Executive Summary

• 3.1. Market Snippet by Synthetic Derivates
• 3.2. Market snippet by Mode of Administration
• 3.3. Market snippet by Application
• 3.4. Market snippet by End User
• 3.5. Market Snippet by Region

4. Global Androgens and Anabolic Steroids Market- Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing prevalence of hypogonadism among males
    • 4.1.1.2. Increasing government funding for healthcare
  • 4.1.2. Restraints:
    • 4.1.2.1. Side effects of steroids on human health
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Global Androgens and Anabolic Steroids Market- Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis

6. Global Androgens and Anabolic Steroids Market- COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. Global Androgens and Anabolic Steroids Market- By Synthetic Derivates

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Synthetic Derivates Segment
  • 7.1.2. Market Attractiveness Index, By Synthetic Derivates Segment
• 7.2. 17 Alpha alkyl derivates*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. 17 Beta ester derivates

8. Global Androgens and Anabolic Steroids Market- By Modes of Administration

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Modes of Administration
  • 8.1.2. Market Attractiveness Index, By Modes of Administration
• 8.2. Oral*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Injection
• 8.4. Topical
• 8.5. Skin Patches
• 8.6. Inhalers

9. Global Androgens and Anabolic Steroids Market- By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User Segment
• 9.2. Hospital Pharmacies*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Retail Pharmacies
• 9.4. Online Pharmacies
• 9.5. Others

10. Global Androgens and Anabolic Steroids Market- By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Synthetic Derivates
  • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modes of Administration
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis ,and Y-o-Y Growth Analysis (%), By End User
  • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Synthetic Derivates
  • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modes of Administration
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%),By End User
  • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  • 10.3.8.
    • 10.3.8.1. Germany
    • 10.3.8.2. U.K.
    • 10.3.8.3. France
    • 10.3.8.4. Italy
    • 10.3.8.5. Spain
    • 10.3.8.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Synthetic Derivates
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modes of Administration
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Synthetic Derivates
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Modes of Administration
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. Australia
    • 10.5.7.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Synthetic Derivates
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modes of Administration
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Androgens and Anabolic Steroids Market- Competitive Landscape

• 11.1. Key Developments and Strategies
• 11.2. Company Share Analysis
• 11.3. Product Benchmarking
• 11.4. Key Companies to Watch

12. Global Androgens and Anabolic Steroids Market- Company Profiles

• 12.1. Endo Pharmaceuticals Solutions Inc*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Valeant
• 12.3. Taro Pharmaceuticals Inc
• 12.4. Antares Pharmaceuticals Inc
• 12.5. Actavis Pharmaceuticals Inc
• 12.6. Pfizer
• 12.7. Unimed Pharmaceuticals
• 12.8. GlaxoSmithKline plc

LIST NOT EXHAUSTIVE

13. Global Androgens and Anabolic Steroids Market- DataM

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us